Unraveling the pathogenesis of HIV peripheral neuropathy : Insights from a simian immunodeficiency virus macaque model

ILAR Journal

Volumn 54, Issue 3, 2014, Pages 296-303

  Mangus, Lisa M ^a   Dorsey, Jamie L ^a   Laast, Victoria A ^b   Ringkamp, Matthias ^c   Ebenezer, Gigi J ^d   Hauer, Peter ^d   Mankowski, Joseph L ^c,d  

^a UNIVERSITY OF BALTIMORE   (United States)

^b R and D   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human immunodeficiency virus (HIV); Macaca nemestrina; Macaque; Peripheral nervous system (PNS); Simian immunodeficiency virus (SIV)

Indexed keywords

ANIMAL; COMPLICATION; DISEASE MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVE REGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSIOLOGY; RHESUS MONKEY; SENSORY GANGLION; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GANGLIA, SENSORY; HIV INFECTIONS; HUMANS; MACACA MULATTA; NERVE REGENERATION; PERIPHERAL NERVOUS SYSTEM DISEASES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84897843380     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilt047     Document Type: Article

References (60)

1. Acharjee S, Noorbakhsh F, Stemkowski PL, Olechowski C, Cohen EA, Ballyani K, Kerr B, Pardo C, Smith PA, Power C. 2010. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J 24:4343-4353.
2. Albers KM, Davis BM. 2007. The skin as a neurotrophic organ. NRO 13:371-382.
3. Bentley CA, Lee KF. 2000. p75 is important for axon growth and schwann cell migration during development. Journal of Neurosci 20:7706-7715.
4. Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RG, White FA. 2009. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Molecular Pain 5:48.
5. Burdo TH, Orzechowski K, Knight HL, Miller AD, Williams K. 2012. Dorsal Root Ganglia Damage in SIV-Infected Rhesus Macaques: An Animal Model of HIV-Induced Sensory Neuropathy. Am J pathol 180:1-8.
6. Canter JA, Haas DW, Kallianpur AR, Ritchie MD, Robbins GK, Schafer RW, Clifford DB, Murdock DG, Hulgan T. 2008. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics Journal 8:71-77.
7. Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo P. 2009. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: Relevance for migraine pathology. Molecular Pain 5:43.
8. Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak M, Tarwater PK, Lifson JD, Zink MC. 2002 The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 186:905-913.
9. Clements JE, Li M, Gama L, Bullock B, Carruth CM, Mankowski JL, Zink MC. 2005. The central nervous system is a viral reservoir in simian immunodeficiency virus-infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. J Neuroviro 11:180-189.
10. Ebenezer G, Laast V, Dearman B, Hauer P., Tarwater PM, Adams RJ, Zink MC, Mc Arthur JC, Mankowski JL. 2009. Altered cutaneous nerve regeneration in a simian immunodeficiency virus/macaque intracutaneous axotomy model. J Comp Neurol 514:272-283.
11. Ebenezer GJ, Hauer P, Gibbons C, Mc Arthur JC, Polydefkis M. 2007. Assessment of epidermal nerve fibers: A new diagnostic and predictive tool for peripheral neuropathies. J Neuropatho Exp Neurol 66:1059-1073.
12. Ebenezer GJ, Mc Arthur JC, Polydefkis M, Dorsey JL, O'donnel R, Hauer P, Adams RJ, Mankowski JL. 2012. SIV-induced impairment of neurovascular repair: a potential role for VEGF. J Neuroviro 18: 222-230.
13. Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, Mc Arthur JC, Simpson DM, Ake C, Collier AC, Gelman BS, Mc Cutchan JA, Morgello S, Grant I, CHARTER Study Group. 2008. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol 64:566-572.
14. Ellis RJ, Rosario D, Clifford DB, Mc Arthur JC, Simpson D, Alexander T, Gelman BS, Vaida F, Collier A, Marra CM, Ances B, Atkinson JH, Dworkin RH, Morgello S, Grant I, CHARTER Study Group. 2010. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: The CHARTER Study. Arch Neurol 67:552-558.
15. Esiri MM, Morris CS, Millard PR.1993. Sensory and sympathetic ganglia in HIV-1 infection: Immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 114:178-187.
16. Evans SR, Ellis RJ, Chen H, Tzu-min Y, Lee AJ, Schiffito G, Wu K, Bosch RJ, Mc Arthur JC, Simpson DM, Clifford DB. 2011. Peripheral neuropathy in HIV: Prevalence and risk factors. AIDS. 25:919-928.
17. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE. 1997. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol 71:5790-5798.
18. Follstaedt SC, Barber SA, Zink MC. 2008. Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: Inhibition of apoptosis signal-regulating kinase 1. J Neurovirol 14:376-388.
19. Ghosh S, Chandran A, Jansen JP. 2012. Epidemiology of HIV-related neuropathy: A systematic literature review. AIDS Res Hum Retroviruses 28:36-48.
20. Gonzalez-Duarte A, Cikurel K, Simpson DM. 2007. Managing HIV peripheral neuropathy. Curr HIV/AIDS Rep 4:114-118.
21. Gonzalez-Duarte A, Robinson-Papp J, Simpson DM. 2008. Diagnosis and management of HIV-associated neuropathy. Neurol Clin 26:821-32.
22. Gosselin R, Suter M, Ji R, Decosterd I. 2010. Glial cells and chronic pain. Neuroscientist 16:519-531.
23. Hahn K, Robinson B, Anderson C, Li W, Pardo CA, Morgello S, Simpson D, Nath A. 2008. Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp Neurol 210:30-40.
24. Höke A. 2012. Animal models of peripheral neuropathies. Neurotherapeutics 9:262-269.
25. Kamerman PR, Moss PJ, Weber J, Wallace VCJ, Rice ASC, Huang W. 2012a. Pathogenesis of HIV-associated sensory neuropathy: Evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 17:19-31.
26. Kamerman PR, Wadley AL, Cherry CL. 2012b. HIV-associated sensory neuropathy: Risk factors and genetics. Curr Pain Headache Rep 16:226-236.
27. Keswani SC, Jack C, Zhou C, Höke A. 2006. Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurol Sci 26:10299-10304.
28. Keswani SC, Pardo CA, Cherry CL, Höke A, Mc Arthur JC. 2002. HIV-associated sensory neuropathies. AIDS 16:2105-2117. Krashin DL, Merrill JO, Trescot AM. 2012. Opioids in the management of HIV-related pain. Pain Physician 15:ES157-168.
29. Krashin DL, Merrill JO, Trescot AM. 2012. Opioids in the management of HIV-related pain. Pain Physician 15:ES157-168.
30. Laast VA, Pardo CA, Tarwater PM, Queen SE, Reinhart TA, Ghosh M, Adams RJ, Zink MC, Mankowski JL. 2007. Pathogenesis of simian immunodeficiency virus-induced alterations in macaque trigeminal ganglia. J Neuropatho Exp Neurol 66:26-34.
31. Laast VA, Shim B, Johanek LM, Dorsey JL, Hauer PE, Pardko CA, Mc Arthur JC, Ringkamp M, Mankowski JL. 2011. Macrophagemediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. Am J Pathol 179:2337-2345.
32. Lauria G, Lombardi R. 2012. Skin biopsy in painful and immune-mediated neuropathies. J Peripher Nerv Syst 17 Suppl 3:38-45.
33. Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD, HIV Outpatient Study Investigators. 2005. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40:148-157.
34. Mankowski JL, Clements JE, Zink MC. 2002. Searching for clues: Tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis 186 Suppl :S199-208.
35. Mankowski JL, Flaherty MT, Spelman JP, Hauer DA, Didier PJ, Amedee AM, Murphey-Corb M., Kirstein LM, Munoz A, Clements JE, Zink MC. 1997. Pathogenesis of simian immunodeficiency virus encephalitis: Viral determinants of neurovirulence. J Virol 71:6055-6060.
36. Mankowski JL, Queen SE, Clements JE, Zink MC. 2004. Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol 157:66-70.
37. Mankowski JL, Queen SE, Fernandez CS, Tarwater PM, Karper JM, Adams RJ, Kent SJ. 2008. Natural host genetic resistance to lentiviral CNS disease: A neuroprotective MHC class I allele in SIV-infected macaques. PloS one 3:e3603.
38. Mc Arthur JC. 2012. Painful small fiber neuropathies. Continuum (Minneap Minn) 18:106-25.
39. Mc Arthur JC, Brew BJ, Nath A. 2005. Neurological complications of HIV infection. Lancet Neurol 4:543-555.
40. Melli G, Keswani SC, Fischer A, Chen W, Höke A. 2006. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 129:1330-1338.
41. Meulendyke KA, Pletnikov MV, Engle EL, Tarwater PM, Graham DR, Zink MC. 2012. Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease. J Neuroimmune Pharmacol 7:454-464.
42. Moyle G. 2000. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clin Ther 22:911- 936; discussion 898.
43. Pardo CA, Mc Arthur JC, Griffin JW. 2001. HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 6:21-27.
44. Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Höke A, Gill MJ, Power C. 2006. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor-mediated neurotoxicity. Ann Neuro 59:816-824.
45. Polydefkis M. 2006. Skin biopsy findings predict development of symptomatic neuropathy in patients with HIV. Nat Clin Pract Neurol 2:650-651.
46. Polydefkis MJ. 2002. Peripheral neuropathy and HIV. Hopkins HIV Rep 14:6-7.
47. Rajan B, Polydefkis M, Hauer P, Griffin JW, Mc Arthur JC. 2003. Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol 457:24-36.
48. Shi Y, Gelman BB, Lisinicchia JG, Tang S-J. 2012. Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients. J Neurol Sci 32:10833-10840.
49. Simpson DM, Tagliati M. 1995. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9:153-161.
50. Sina ST, Ren W, Cheng-Mayer C. 2011. Coreceptor use in nonhuman primate models of HIV infection. J Transl Med 9 Suppl 1:S7.
51. Smith HS. 2011. Treatment considerations in painful HIV-related neuropathy. Pain Physician 14:E505-524.
52. Smyth K, Affandi JS, Mc Arthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IL, Price P, Wesselingh SL, Cherry CL. 2007. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med 8:367-373.
53. Song XY, Zhou FH, Zhong JH, Wu LL, Zhao XF. 2006. Knockout of p75 (NTR) impairs re-myelination of injured sciatic nerve in mice. J Neurochem 96:833-842.
54. Thompson DM, Buettner HM. 2006. Neurite outgrowth is directed by schwann cell alignment in the absence of other guidance cues. Ann Biomed Eng 34:161-168.
55. Villa G, Fumagalli M, Verderio C, Abbrachi MP, Ceruti S. 2010. Expression and contribution of satellite glial cells purinoceptors to pain transmission in sensory ganglia: An update. Neuron Glia Biol 6:31-42.
56. Wendelschafer-Crabb G, Kennedy WR, Walk D. 2006. Morphological features of nerves in skin biopsies. J Neurol Sci 242:15-21.
57. Wiebe LA, Phillips TJ, Li JM, Allen JA, Shetty K. 2011. Pain in HIV: An evolving epidemic. J Pain 12:619-624.
58. Zheng W, Ouyang H, Zheng X, Liu S, Mata M, Fink DJ, Hao S. 2011. Glial TNFa in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain 7:40.
59. Zink MC, Amedee AM, Mankowski JL, Craig LE, Didier P, Carter DL, Munoz A, Murphy-Corb M, Clements JE. 1997. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol 151:793-803.
60. Zink MC, Brice AK, Kelly KM, Queen SE, Gama L, Li M, Adams RJ, Bartizal C, Varrone J, Rabi SA, Graham DR, Tarwater PM, Mankowski JL, Clements JE. 2010. Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis 202:161-170.